Brazilian regulator denied half of high risk medical device registrations in 2016

By Stewart Eisenhart, Emergo Group Nearly half of some higher-risk registration applications to Brazilian medical device regulator ANVISA were rejected in 2016, according to the agency’s own performance report. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect

Are the BRIC markets still worth the effort?

Stewart Eisenhart / Senior Regulatory Analyst / Emergo Group If the title of this article sounds pessimistic, it’s for a reason. Compared to the highly evolved medical device markets in the U.S., Europe and Japan, the growing BRIC markets–Brazil, Russia, India and China–continue to perplex new entrants. The BRIC markets have long been pursued by device